CB47782-23 - 0x000000000000690D
Healthy Males & Females
Mesmerize
* Stipend may pay up to reflected amount.
Start Date:
September 11, 2026 - 3:00pm
End Date:
October 10, 2026 - 10:00am
Study Details
Study Number: CB47782
Group Number: 23
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat schizophrenia.
Route of Administration: Oral
Blood Draws: 50
Study Schedule
Schedule Type: Long Term
Study Length: 17 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 9/2/2026 |
| Tuesday | 9/8/2026 |
| Thursday | 9/10/2026 |
| Friday | 9/11/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Wednesday | 9/2/2026 |
| Tuesday | 9/8/2026 |
| Thursday | 9/10/2026 |
| Friday | 9/11/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Friday | 9/11/2026 3:00:00 PM | Monday | 9/28/2026 10:00:00 AM | 1 | Lincoln |
| Return | Saturday | 10/3/2026 8:30:00 AM | Saturday | 10/3/2026 10:00:00 AM | 1 | Lincoln |
| Return | Saturday | 10/10/2026 8:30:00 AM | Saturday | 10/10/2026 10:00:00 AM | 1 | Lincoln |
